COPD診療のエッセンス - dl.med.or.jp

1 100m copd copd copd 3 40 10 3 FEV1/FVC< copd X 50% copd 40 copd copd 11 1.

2 2. 17 copd 16 copd 1 40 49 050 59 460 69 870 10 1 1 0 2990300 4992500 99931000 7 BMI kg m 2 BMI 3 0 0 3 0 0 3 0 4

3 0 3 IPAG 2005 SABAand/orSAMA LAMA or LABA LAMA LAMA and LABA ICS 4 orLABA ICS SABA Short-acting 2-agonist 2 SAMA Short-acting muscarinic antagonist LAMA Long-acting muscarinic antagonist LABA Long-acting 2-agonist 2 ICS Inhaled corticosteroids copd BMI 5 copd 12 copd SpO2>93% 3 SpO2<90% copd copd copd copd copd copd SABA

4 20 30mg 7 10 ADL HOT SpO2 90 48 13 14 15 SpO2: 2 SABA 1 200 g 2 1-2 MDI 1 20 g 2 DPI SAMA 1 100-200 g 1-2 3 / 1 20-40 g 1-2 3-4 / LAMA 1 18 g 1 1 / LAMA 1 1 5 g 2 1 / 2 (LABA)

5 1 50 g 1 2 1 1-2mg 1 2 LABA / ICS / 250 DPI 1 1 2 / 125 MDI 1 2 2 / ICS ICS copd 1 100-200mg 2 / 1 100-200mg 2 / LA 1 200-400mg 1 / 1 4mg 3 / DS 1 500mg 3 / 1 400mg 3 / DS 1 15mg 3 / L 1 45mg 1 / copd ( ) copd 162010 12